2018 AAFP Vaccine Science Fellowship

Application Deadline is June 4, 2018


About the Fellowship

The American Academy of Family Physicians (AAFP) has two vaccine science fellowship positions available for family physicians. The selected fellows will work with mentors to become more knowledgeable about vaccine science and policy.

The selected applicants will have the opportunity to gain knowledge and practical hands-on experience through participation in meetings with leading experts in public health and immunizations, federal and state vaccine policy groups, and vaccine manufacturers. 


Purpose

The overall intent of the program is to develop a cadre of family physicians interested in and knowledgeable about vaccines issues. Application priority will be given to family physicians that have a position of policy making regarding vaccines, teaching about vaccines, research on vaccines, or background in clinical policy/guideline development.

This cadre of family physician vaccine experts will assist the AAFP in providing effective input into the deliberations and decisions of federal and state public health agencies that set vaccine policies, as well as educating practicing family physicians about advances in vaccines. This fellowship will address the interface between public health and the family physician community to make vaccine information effective and practical to the membership of the AAFP. The proposed outcome will be improved use of immunizations by the U.S. public and the highest level possible of vaccine safety and public acceptance of vaccines. 

Fellowship Application

To apply for the 2018 AAFP Vaccine Science Fellowship, please submit the following materials to Pamela Carter-Smith, MPA:

  • Curriculum vitae (CV)
  • Letter of interest
  • Completed conflict of interest form 
  • Institution and/or department letter
  • Photo of applicant

Application Deadline is June 4, 2018.

 

Questions?

[ ]

Please contact Pamela Carter-Smith, MPA Clinical Policies Strategist, at pcarter@aafp.org or 800-274-2237, ext. 3162.


Fellowship Description

The purpose of the fellowship is to develop a cadre of family physicians who are interested in the science of vaccine development and production as well as vaccine policy.  This program is designed to be of particular assistance to those who are mid-career in their professional development. The awards will be granted to two fellows annually. Each fellow will work with mentors who are experienced in immunization policy and issues.

  • The fellowship is for one year with the commitment from their institution and/or department chair that they will allow the time to complete the fellowship. The fellowship period will be July 1, 2018 – June 30, 2019.
  • Each fellow will devote approximately 10% FTE for one year (approximately 22 days). A nominal stipend will be provided.
  • The fellows will develop a self-study project on HPV, with a specific focus on patients 19-26 years of age. The project will be disseminated to the following audience: AAFP membership, public health officials, other immunization organizations, etc. This self-study project will consist of a poster presentation, articles, research projects, education outreach, etc.
  • The fellow will be required to dedicate time for travel to be involved with vaccine related meetings.  Travel costs will be covered under the fellowship. The fellow will attend approximately 7 meetings during the term of the fellowship.  Proposed meetings include: Advisory Committee on Immunization Practices; National Vaccine Advisory Committee; National Immunization Conference; Centers for Disease Control and Prevention; Washington DC to meet key governmental staff; Vaccine Manufacturers; and the Wisconsin Council on Immunization Practices meeting and/or the Wisconsin State Immunization Program.

Please Note: The fellows will need to attend one of the following Advisory Committee on Immunization Practices meetings:  October 24-25, 2018 or February 27-28, 2019 in Atlanta, Georgia.     


Eligibility Requirements

  • Applicant must be an active category member of the American Academy of Family Physicians, in practice or teaching, and out of residency and fellowship.
  • Applicant must be a U.S. citizen.
  • Applicant must submit a curriculum vitae (CV) and letter of interest.
  • Applicant must complete AAFP’s conflict of interest form. In addition, applicant must have minimal or no FINANCIAL conflicts of interest related to entities that provide manufacturing and/or distribution of vaccines or related products. (Priority will be given to applicants that are free of conflicts of interest).
  • Each applicant must devote approximately 10% of full-time employment (FTE) for one year.
  • Applicant’s institution, practice, and/or department chair must submit a letter agreeing to commit 10% of FTE protected time for the applicant to complete the fellowship.
  • Applicant must commit to travel time for appropriate meetings (see Fellowship Description.
  • Because funding support for the AAFP Vaccine Science Fellowships is provided by Merck & Co., Inc., the selected applicants may be disclosed by Merck and posted on a public website by the Centers for Medicare & Medicaid Services as covered recipients under the Physician Payments Sunshine Act, codified at 42 CFR, Parts 402 and 403. The funder will have no input into or control over selection of fellows or content of the fellowships.

Submitting Your Fellowship Application

To apply, please submit the following materials to Pamela Carter-Smith, MPA, Clinical Policies Strategist:

  • CV
  • Letter of Interest
  • Letter from your institution and/or department chair stating that it is agreed that 10% of FTE protected time will be allowed for you to complete the fellowship.
  • Photo of applicant

Applications will be acknowledged via email upon receipt. If acknowledgement has not been received, please contact Ms. Carter-Smith.

REVIEW COMMITTEE AND SELECTION:

Applications will be reviewed and awardees selected by a review committee independent of any supporter involvement. The awardees will be notified via e-mail by June 18, 2018.